Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy alone for EGFR-mutated resectable non-small-cell lung cancer: NeoADAURA
暂无分享,去创建一个
M. Tsuboi | Y. Yatabe | S. Dacic | C. Escriu | J. Chaft | Jianxing He | C. Blakely | W. Weder | A. Walding | L. Zeng